Algernon Pharmaceuticals Equity 2024

Equity Details

Analyzing Algernon Pharmaceuticals's Equity

Algernon Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Algernon Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Algernon Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Algernon Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Algernon Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Algernon Pharmaceuticals Stock

What is the equity of Algernon Pharmaceuticals this year?

Algernon Pharmaceuticals has equity of 1.47 M CAD this year.

What was the equity of Algernon Pharmaceuticals compared to the previous year?

The equity of Algernon Pharmaceuticals has increased/decreased by -73.8% decreased compared to the previous year.

What impact does a high equity have on investors of Algernon Pharmaceuticals?

A high equity is advantageous for investors of Algernon Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Algernon Pharmaceuticals?

A low equity can be a risk for investors of Algernon Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Algernon Pharmaceuticals affect the company?

An increase in equity of Algernon Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Algernon Pharmaceuticals affect the company?

A reduction in equity of Algernon Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Algernon Pharmaceuticals?

Some factors that can affect the equity of Algernon Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Algernon Pharmaceuticals so important for investors?

The equity of Algernon Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Algernon Pharmaceuticals take to change the equity?

To change equity, Algernon Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Algernon Pharmaceuticals pay?

Over the past 12 months, Algernon Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Algernon Pharmaceuticals is expected to pay a dividend of 0 CAD.

What is the dividend yield of Algernon Pharmaceuticals?

The current dividend yield of Algernon Pharmaceuticals is .

When does Algernon Pharmaceuticals pay dividends?

Algernon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Algernon Pharmaceuticals?

Algernon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Algernon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Algernon Pharmaceuticals located?

Algernon Pharmaceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Algernon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Algernon Pharmaceuticals from 6/24/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/24/2024.

When did Algernon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Algernon Pharmaceuticals in the year 2023?

In the year 2023, Algernon Pharmaceuticals distributed 0 CAD as dividends.

In which currency does Algernon Pharmaceuticals pay out the dividend?

The dividends of Algernon Pharmaceuticals are distributed in CAD.